Cargando…

Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine

Detalles Bibliográficos
Autores principales:	Gaignard, Marie-Estelle, Lieberherr, Sven, Schoenenberger, Andreas, Benz, Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/ https://www.ncbi.nlm.nih.gov/pubmed/34263143 http://dx.doi.org/10.1097/HS9.0000000000000618

Ejemplares similares

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

COVID-19 Vaccines and Autoimmune Hematologic Disorders
por: Mingot-Castellano, María Eva, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
por: Fatima, Zainab, et al.
Publicado: (2022)

Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
por: Agha, Mounzer, et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases
por: Zamfir, Maria-Alexandra, et al.
Publicado: (2022)

The Risk of Autoimmunity Development following mRNA COVID-19 Vaccination
por: Świerkot, Jerzy, et al.
Publicado: (2022)

Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination
por: Ju, Hyun Jeong, et al.
Publicado: (2023)

Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
por: Filippini, Federica, et al.
Publicado: (2023)

The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study
por: Gueguen, M., et al.
Publicado: (2022)

The mRNA COVID-19 vaccine – A rare trigger of autoimmune hepatitis?
por: McShane, Cathy, et al.
Publicado: (2021)

Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases
por: Kato, Yasuhiro, et al.
Publicado: (2023)

Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy
por: Mencoboni, Manlio, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
por: Pascale, Sara Pasquina, et al.
Publicado: (2022)

mRNA-1273: Autoimmune hepatitis: case report
Publicado: (2021)

mRNA-1273: Autoimmune hepatitis: case report
Publicado: (2021)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
por: Mohamed, Libin, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

A qualitative study on existential suffering and assisted suicide in Switzerland
por: Gaignard, Marie-Estelle, et al.
Publicado: (2019)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

mRNA-1273: Autoimmune haemolytic anaemia: case report
Publicado: (2021)

Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study
por: Giannoccaro, Maria Pia, et al.
Publicado: (2022)

Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies
por: Greenberger, Lee M., et al.
Publicado: (2022)

Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
por: Mesina, Flordeluna Z.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccination-induced Autoimmune Polyarthritis-like Rheumatoid Arthritis
por: Abe, Nobuya, et al.
Publicado: (2022)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

Variant constraint by mRNA vaccines
por: Bordon, Yvonne
Publicado: (2021)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3avm9fj7uhdfj8s8bhr23re31